Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Activating MAP KAP kinase 2.

Ernst ter Haar

    Structure (London, England : 1993)
    |June 7, 2003
    PubMed
    Summary

    MAP KAP kinase 2 undergoes significant structural changes when binding to ADP and staurosporine. Its catalytic activity is primarily determined by phosphorylation from p38 MAP kinase.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Fragment-Based Discovery of Dual JC Virus and BK Virus Helicase Inhibitors.

    Journal of medicinal chemistry·2016
    Same author

    Insights into regioselective metabolism of mefenamic acid by cytochrome P450 BM3 mutants through crystallography, docking, molecular dynamics, and free energy calculations.

    Proteins·2016
    Same author

    Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism.

    Structure (London, England : 1993)·2010
    Same author

    3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3beta.

    Bioorganic & medicinal chemistry letters·2010
    Same author

    Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control.

    Journal of medicinal chemistry·2009
    Same author

    Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK).

    Bioorganic & medicinal chemistry letters·2008

    Area of Science:

    • Biochemistry
    • Structural Biology
    • Enzymology

    Background:

    • MAP KAP kinase 2 (MK2) is a key downstream kinase in the p38 mitogen-activated protein kinase (MAPK) pathway.
    • Understanding MK2's structure and regulation is crucial for developing targeted therapeutics for inflammatory diseases and cancer.

    Discussion:

    • The crystal structures reveal a dynamic glycine-rich loop in MK2 that undergoes substantial reorganization upon binding of ADP and staurosporine.
    • This conformational change likely plays a critical role in modulating enzyme activity and substrate recognition.

    Key Insights:

    • Ligand binding, specifically to ADP and staurosporine, induces a major structural rearrangement in the glycine-rich loop of MAP KAP kinase 2.
    • Phosphorylation by p38 MAP kinase is identified as the principal factor governing the catalytic activity of MAP KAP kinase 2.

    Outlook:

    • Further structural and biochemical studies could elucidate the precise mechanisms of MK2 activation and inhibition.
    • Targeting the structural plasticity of the glycine-rich loop may offer novel therapeutic strategies for modulating MK2 activity.

    Related Experiment Videos